CSBR - CIK 0000771856
CHAMPIONS ONCOLOGY, INC. (CSBR) reported revenue of $56.94M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $56.94M | +13.5% |
| FY 2024 | $50.16M | -6.9% |
| FY 2023 | $53.87M | +9.7% |
| FY 2022 | $49.11M | +19.7% |
| FY 2021 | $41.04M | +27.8% |
| FY 2020 | $32.12M | +1007.7% |
| FY 2019 | $2.90M | -85.7% |
| FY 2018 | $20.24M | - |
CHAMPIONS ONCOLOGY, INC. (CSBR) reported revenue of $56.94M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2025, CHAMPIONS ONCOLOGY, INC.'s revenue grew from $20.24M to $56.94M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.